Consumer Directed Benefit Solutions

It's not a good news day for Big Pharma as we have a second report regarding eye-popping price markups - in this case in the vaunted mail-order prescriptions arena. This is another example of an area where the original good intentions of a program/industry can morph into something different over time and without serious oversight.

Mail-order pharmacies add much bigger markups: Washington state groups For brand-name drugs, the average margin gap may be more than $65 per 30-day prescription.